Brian Millham - 22 Dec 2023 Form 4 Insider Report for Salesforce, Inc. (CRM)

Reporting relationship: President and COO
Issuer ticker: CRM
Reported as of: 22 Dec 2023
Net transaction value: -$849,728
SEC form: 4
Accepted by SEC: 26 Dec 2023, 21:20:25 UTC
Prior SEC filing: 04 Dec 2023
Next SEC filing: 28 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Sarah Dale, Attorney-in-Fact for Brian Millham

Key filing fact

Brian Millham filed Form 4 for Salesforce, Inc. (CRM) on 26 Dec 2023.

Key facts

This page summarizes Brian Millham's Form 4 filing for Salesforce, Inc. (CRM).
13 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 26 Dec 2023, 21:20.

Change

Previous filing in this sequence was filed on 04 Dec 2023.
Current net transaction value: -$849,728.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRM transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,634
Change %
Price: $0.000000
Shares after: 1,634
Date: 22 Dec 2023
Ownership: Direct

CRM transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,706
Change %: +104%
Price: $0.000000
Shares after: 3,340
Date: 22 Dec 2023
Ownership: Direct

CRM transaction

Common Stock

Options Exercise

Transaction value: $433,998
Shares: +2,017
Change %: +60%
Price: $215.17
Shares after: 5,357
Date: 22 Dec 2023
Ownership: Direct
Footnotes: F1

CRM transaction

Common Stock

Options Exercise

Transaction value: $459,768
Shares: +2,107
Change %: +39%
Price: $218.21
Shares after: 7,464
Date: 22 Dec 2023
Ownership: Direct
Footnotes: F1

CRM transaction

Common Stock

Options Exercise

Transaction value: $269,128
Shares: +1,746
Change %: +23%
Price: $154.14
Shares after: 9,210
Date: 22 Dec 2023
Ownership: Direct
Footnotes: F1

CRM transaction

Common Stock

Sale

Transaction value: $1,567,290
Shares: -5,870
Change %: -64%
Price: $267.00
Shares after: 3,340
Date: 22 Dec 2023
Ownership: Direct
Footnotes: F1

CRM transaction

Common Stock

Sale

Transaction value: $217,889
Shares: -821
Change %: -25%
Price: $265.39
Shares after: 2,519
Date: 26 Dec 2023
Ownership: Direct
Footnotes: F2

CRM transaction

Common Stock

Sale

Transaction value: $227,443
Shares: -857
Change %: -34%
Price: $265.39
Shares after: 1,662
Date: 26 Dec 2023
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,634
Change %: -17%
Price: $0.000000
Shares after: 8,173
Date: 22 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,634
Exercise price: $0.000000
Footnotes: F3, F4

CRM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,706
Change %: -10%
Price: $0.000000
Shares after: 15,359
Date: 22 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,706
Exercise price: $0.000000
Footnotes: F3, F5

CRM transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -2,017
Change %: -6.2%
Price: $0.000000
Shares after: 30,268
Date: 22 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,017
Exercise price: $215.17
Footnotes: F6

CRM transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -2,107
Change %: -3.6%
Price: $0.000000
Shares after: 56,880
Date: 22 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,107
Exercise price: $218.21
Footnotes: F7

CRM transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -1,746
Change %: -20%
Price: $0.000000
Shares after: 6,982
Date: 22 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,746
Exercise price: $154.14
Footnotes: F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 8 footnotes

Footnote F1

As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2023.

Footnote F2

Represents a sale of shares to satisfy the tax withholding obligations of the Issuer with respect to the settlement of shares that were earned by the holder pursuant to a restricted stock unit award that vested based on the holder's continued employment through December 22, 2023.

Footnote F3

Restricted Stock Units convert to shares of common stock on a one-for-one basis.

Footnote F4

These restricted stock units vest as to 25% of the original grant on March 22, 2022, and vest as to 1/16 of the original grant quarterly thereafter.

Footnote F5

These restricted stock units vest as to 25% of the original grant on March 22, 2023 and vest as to 1/16 of the original grant quarterly thereafter.

Footnote F6

Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F7

Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F8

Option is exercisable and vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.